1:19-CV-00394 | 2019-05-17, U.S. District Courts | Civil Right | Ct. App. Id. The Court denies AIS's motion on this claim. (Attachments: #1 Index of Exhibits, #2 Exhibit 1 - BCBS Agreement, #3 Exhibit 2 - Letter from BCBS, #4 Exhibit 3 - Letter from Sheppard Mullin) (Winsten, I.) D/B/A ADVANCED INFUSION CARE Court:United States District Court, Eastern District of Louisiana Date published: Jul 30, 2021 CitationsCopy Citation Civil Action 21-774 (E.D. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. Before sharing sensitive information, make sure you're on a federal government site. AIS moves to dismiss BCBS and AHS's counter claims under Rule 12(b)(6). (citing Twombly, 550 U.S. at 555). These allegations are sufficient to plausibly state a claim for breach of good faith and fair dealing. Rule 9(b) requires a party to plead with particularity the circumstances constituting fraud. Id. Human Drug Compounding, Recalls, Market Withdrawals and Safety Alerts, Compounding Quality Center of Excellence On-demand Training, Compounding Oversight and Compliance Actions, Compounding: Inspections, Recalls, and other Actions, Consumer and Health Care Professional Information, Guidance, Compliance, & Regulatory Information, 2014 - 2015 Compounding: Inspections, Recalls, and other Actions, Referral Letter to the California State Board of Pharmacy Issued 07/06/2020, Referral Letter to the Florida State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Virginia State Board of Pharmacy dated 01/29/2020, Referral Letter to the Missouri Board of Pharmacy dated 06/16/2022, Referral Letter to the Nevada State Board of Pharmacy dated 07/13/2022, Referral Letter to the Virginia State Board of Pharmacy Issued 06/08/2017, Referral Letter to the New York State Board of Pharmacy Issued 05/08/2017, Referral Letter to the Delaware State Board of Pharmacy Issued 04/28/2017, Referral Letter to Florida State Board of Pharmacy Issued 10/09/2015, Referral Letter to the New York State Board of Pharmacy Issued 03/22/2017, Referral Letter to Florida Board of Pharmacy Issued 02/21/2014, Referral Letter to State of New Hampshire Board of Pharmacy Issued 06/07/2016, Referral Letter to the Kansas State Board of Pharmacy Issued 03/06/2019, Referral Letter to the North Carolina State Board of Pharmacy Issued 08/19/2019, Referral Letter to the Arizona State Board of Pharmacy Issued 04/09/2020, Referral to the Rhode Island State Board of Pharmacy Issued 07/25/2017, Referral Letter to the California State Board of Pharmacy Issued 08/31/2017, Referral to the New York State Board of Pharmacy Issued 11/16/2017, Referral Letter to the Mississippi Board of Pharmacy Issued 08/02/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 10/29/2019, Referral Letter to the Ohio State Board of Pharmacy Issued 05/01/2019, Referral Letter to the Florida Board of Pharmacy Issued on 01/31/17, Referral Letter to the Georgia State Board of Pharmacy Issued 11/18/2019, Referral to the Connecticut State Board of Pharmacy Issued 07/12/2017, Referral Letter to the Louisiana Board of Pharmacy Issued 11/03/2022, Referral Letter to the Michigan Board of Pharmacy Issued 03/22/2017, Referral Letter to the Ohio State Board of Pharmacy Issued 08/09/17, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 01/17/17, Referral Letter to the California State Board of Pharmacy Issued 07/20/2020, FDA Alerts Health Care Professionals and Patients not to Use Sterile Drug Products from Chen Shwezin Inc., dba Park Compounding Pharmacy, Referral Letter to the Michigan Board of Pharmacy Issued 09/09/16, Referral Letter to the Ohio Board of Pharmacy Issued 05/30/2014, Referral Letter to the Mississippi State Board of Pharmacy Issued 11/05/2019 Shutdown Letter, Referral Letter to the Mississippi Board of Pharmacy Issued 06/27/2019, Referral Letter to the Georgia State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Indiana State Board of Pharmacy Issued 10/02/2019, Referral Letter to the Arkansas State Board of Pharmacy Issued 10/28/2020, Referral Letter to the California State Board of Pharmacy Issued 12/14/2015, Leader of $17 Million Health Insurance Fraud Scheme Ordered to Prison, Referral Letter to the Texas State Board of Pharmacy Issued 05/18/2020, FDA Requested Recall Letter Issued 09/09/2014, FDA Requested Recall Letter Issued 07/26/2013, Referral Letter to New Jersey State Board of Pharmacy Issued 02/21/2014, Referral Letter to the Georgia State Board of Pharmacy Issued 05/19/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/29/2019, FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding, Referral Letter to Missouri Board of Pharmacy Issued 02/26/2014, Referral Letter to the Alaska State Board of Pharmacy dated 02/18/2020, Referral Letter to the Alaska State Board of Pharmacy dated 02/06/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/08/2017, FDAs Investigation into Guardians Compounded Triamcinolone-Moxifloxacin Drug Product, FDA Alerts Health Care Professionals of Adverse Events Associated with Guardians Compounded Triamcinolone and Moxifloxacin Product for Intravitreal Injection, Corrected (No Redactions) 483 Issued 10/21/2016, Referral Letter to the Texas State Board of Pharmacy Issued 03/24/2021, Referral to the California State Board of Pharmacy Issued 09/26/2017, Referral Letter to the Michigan State Department of Licensing and Regulatory Affairs (LARA) Issued 05/21/2015, Referral Letter to the Florida State Board of Pharmacy Issued 01/23/2017, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 03/27/2014, Referral Letter to the Texas State Board of Pharmacy Issued 05/05/2016, Referral Letter to the Maryland State Board of Pharmacy Issued 08/23/2019, A Case of Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation, FDA Investigates Two Serious Adverse Events Associated with ImprimisRxs Compounded Curcumin Emulsion Product for Injection, Investigation Memo and Attachments, 08/16/2011, Referral Letter to the Minnesota State Board of Pharmacy Issued 07/01/2019, Referral to the South Carolina State Board of Pharmacy Issued 09/13/2017, Referral Letter to the Ohio Board of Pharmacy Issued 03/28/2019, Referral Letter to the ColoradoBoard of Pharmacy Issued 12/23/2020, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 10/03/2019, Referral Letter to the New Mexico State Board of Pharmacy Issued 08/22/2017, Maxor National Pharmacy Services Corporation, Referral Letter to the Texas Board of Pharmacy Issued 03/18/2014, Alexandria Medical Arts Pharmacy & Compounding Laboratory, Referral Letter to the Florida Board of Pharmacy Issued 04/21/2017, FDA announces Glades Drugs nationwide voluntary recall of Compounded Multivitamins containing High Amounts of Vitamin D3 (Cholecalciferol), Referral Letter to the California State Board of Pharmacy Issued 12/06/2019, Referral Letter to the Missouri State Board of Pharmacy Issued 01/10/2017, Referral Letter to the Missouri State Board of Pharmacy Issued 03/10/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 08/11/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 09/11/2019, Referral Letter to the New York State Board of Pharmacy Issued 11/15/2019, Referral Letter to the California State Board of Pharmacy Issued 11/22/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 07/11/2019, Referral Letter to Oklahoma State Board of Pharmacy Issued 02/25/2014, Referral Letter to the New York State Board of Pharmacy Issued 06/06/2019, Referral Letter to the Massachusetts Department of Public Health Issued 10/14/2015, Referral to the New York State Education Department, Office of the Professions, Pharmacy Issued 07/07/2017, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/10/2019, Referral Letter to the Oklahoma State Board of Pharmacy Issued 10/2/2020, Referral Letter to the Missouri Board of Pharmacy Issued 02/18/2015, FDA Requested Recall Letter Issued 05/03/2016, Referral Letter to the South Carolina State Board of Pharmacy Issued 05/21/2015, Referral to the Texas State Board of Pharmacy Issued 07/28/2017, State Referral Letter to the Nevada State Board of Pharmacy issued 12/06/2017, Referral Letter to Massachusetts Board of Registration in Pharmacy Issued 01/20/2016, Barclay Luke & Pillai Specialty Pharmacy PLLC, Referral Letter to the Arizona State Board of Pharmacy Issued 05/23/2017, Referral Letter to the Michigan State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Tennessee Board of Pharmacy Issued 04/05/2017, Referral Letter to the Wisconsin State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 05/09/2016, Unlicensed Pharmacy Technician Sentenced for Working at New England Compounding Center, Owner and Four Former Employees of New England Compounding Center Convicted Following Trial, Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center, Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud, Multistate outbreak of fungal meningitis and other infections, Referral to the Massachusetts State Board of Registration in Pharmacy Issued 09/26/2017, Referral Letter to New Hampshire State Board of Pharmacy Issued 04/29/2015, Referral Letter to the Kentucky State Board of Pharmacy Issued 03/04/2020, Referral to the Kansas State Board of Pharmacy Issued 06/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 07/01/2020, Referral Letter to the Illinois State Board of Pharmacy Issued 10/31/2019, Referral Letter to the California State Board of Pharmacy Issued 07/08/2020, Referral Letter to Florida State Board of Pharmacy Issued 03/10/2021, Amended 483 and Cover Letter Issued 04/09/2013 and 483 Issued 03/29/2013, Referral Letter to the Tennessee State Board of Pharmacy Issued 09/13/2019, Referral Letter to the Florida State Board of Pharmacy Issued 04/22/2019, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 05/05/2017, Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients, Referral Letter to the Texas State Board of Pharmacy Issued 03/12/2019, Referral Letter to the Kansas State Board of Pharmacy Issued 03/29/2017, Pharmacy Creations Issues Voluntary Recall of Four Product Lots With Limited Distribution in Florida, New Jersey, New York, and Puerto Rico Due to Potential Non-Sterility (09/04/2014), Referral Letter to the Indiana State Board of Pharmacy Issued 03/06/2017, Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Drugs, Referral Letter to the New Jersey State Board of Pharmacy Issued 07/29/2019, Referral to the Oklahoma State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Georgia State Board of Pharmacy Issued 08/14/2020, Referral Letter to New York State Board of Pharmacy Issued 11/07/2016, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/11/2017, Referral Letter to Michigan Board of Pharmacy Issued 02/25/2014, Referral Letter to the California State Board of Pharmacy Issued 04/05/2017, Referral Letter to the Colorado State Board of Pharmacy Issued 04/14/2020, Referral Letter to the FloridaBoard of Pharmacy Issued 07/27/2022, Referral Letter to the Ohio State Board of Pharmacy Issued 09/12/2019, Referral to the New York State Board of Pharmacy Issued 06/15/2017. Corp. v. Twombly,550 U.S. 544, 556 (2007)). Transcript Order ddl satisfied. (LSau) (Entered: 02/18/2021), Docket(#6) STIPULATION by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions (Winsten, I.) A U.S. District Court judge in West Virginia last week denied Medtronic's motion to dismiss the lawsuit brought by John David Brumfield, who claims that the pump in the SynchroMed II device he had implanted in 2012 to treat back pain stopped delivering the pain medication hydromorphone in 2018. The system is commonly used in hospitals and. (Court Reporter/Transcriber: Sheri Ward, www.transcriptorders.com) (Number of Pages: 21) The parties have 21 days to file with the court and Court Reporter/Transcriber a Redaction Request of this transcript. Case Number: 21-30534. (Ward, S) (Entered: 07/06/2021), Minute Entry for proceedings before District Judge Denise Page Hood: Motion Hearing held on 6/23/2021 re #18 MOTION to Dismiss Plaintiff's Amended Complaint filed by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions Disposition: Motion taken under advisement (Court Reporter: Sheri Ward) (LSau) (Entered: 06/24/2021), (#24) REPLY to Response re #18 MOTION to Dismiss Plaintiff's Amended Complaint filed by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Click the citation to see the full text of the cited case. Salaries below this are outliers. may be available from PACER. AHS is a subsidiary of BCBS that maintains and operates BCBS provider networks in Mississippi. Image Trademark. [21-30534] (SEP) [Entered: 09/15/2021 03:32 PM], APPEARANCE FORM FILED by Attorney Timothy Richardson for Appellant Randy Denning in 21-30534. $24,000 - $37,999 10% of jobs $38,000 - $51,999 12% of jobs $57,000 is the 25th percentile. The Court therefore denies AIS's motion on this claim. [21-30534] (DLJ) [Entered: 09/08/2021 12:40 PM], PRIVATE CIVIL DIVERSITY CASE docketed. Electronic ROA due on 09/30/2021. 2022 Beckoning-cat.com. (LSau) (Entered: 04/06/2021), Docket(#10) NOTICE of Appearance by Paul Anthony Werner, III on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Date of service: 10/19/2021 via email - Attorney for Appellants: Burns, Camel, Richardson; Attorney for Appellees: Matini, Patron, Spencer-Davis, Werner [21-30534] (Roberta Louise Burns ) [Entered: 10/19/2021 02:16 PM], APPEARANCE FORM for the court's review. [21-30534] (SEP) [Entered: 09/15/2021 10:19 AM], APPEARANCE FORM for the court's review. Id. No. In contrast, BCBS and AHS claim they set forth factual descriptions and direct allegations constituting AIS's fraudulent scheme, such that AIS has notice. Click on the case name to see the full text of the citing case. Specialty, Ltd. Austin, TX- 503A Facility - Out of business, J & F International Inc.(dba Alexandria Medical Arts Pharmacy & Compounding Laboratory), Alexandria, VA- 503A Facility, Jack P. Herick Inc. (dba Glades Drugs), Pahokee, FL- 503A Facility, Jacobs Pills Inc. (dba The Healthy Choice Apothecary), Elmsford, NY- 503A Facility, Jajco Inc. (dba Anchor Drugs Pharmacy), South San Francisco, CA- 503A Facility, JCB Laboratories, LLC, Wichita, KS- 503A Facility - Out of business, JD & SN Inc. (dba Moses Lake Professional Pharmacy), Moses Lake, WA- 503A Facility, Jeffreys Drug Store, Canonsburg, PA- 503A Facility, Joe Wise Pharmacy, Inc., (dba Wise Pharmacy), Littleton, CO- 503A Facility - Out of business, John Hollis Pharmacy, (see John W. Hollis, Inc.), Nashville, TN- 503A Facility, John W. Hollis, Inc.(dba John Hollis Pharmacy), Nashville, TN- 503A Facility, John L. McClellan Memorial Veterans Hospital, Little Rock, AR- 503A Facility, John's Pharmacy, Inc.,(dba The Sullivan Pharmacy), Sullivan, IL- 503A Facility, Johns Pharmacy LLLP, Cape Girardeau, MO- 503A Facility, Johnson Compounding and Wellness,(see Merissa Corp.), Waltham, MA- 503A Facility, Johnson Memorial Cancer Center, Enfield, CT- 503A Facility, Jones Drug Company, Inc., (dba Reed's Compounding Pharmacy), Tucson, AZ- 503A Facility, Jubilant DraxImage Radiopharmacies, Inc., (dba Triad Isotopes, Inc.), Kansas City, MO- 503A Facility, Jubilant HollisterStier, LLC, Spokane, WA- 503A Facility - De-registered as an Outsourcing Facility, Jungle Jim's Pharmacy, Fairfield, OH- 503A Facility, J.W. See Order [61]. Motion Hearing set for 6/9/2021 02:30 PM before District Judge Denise Page Hood |Zoom Webinar Information: https://www.zoomgov.com/j/1616326086?pwd=dTVZRnlseVBTNFRhNVE0SlhQaEozUT09 Passcode: 999999 Or One tap mobile : US: +16692545252,,1616326086# or +16468287666,,1616326086#| (LSau) (Entered: 04/21/2021), (#19) NOTICE of Appearance by Rian Cierra Dawson on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Lead Counsel? AIS argues that BCBS and AHS merely provide a "formulaic recitation of the elements." Advanced Infusion Solutions is a provider established in Ridgeland, Mississippi operating as a Pharmacy with a focus in home infusion therapy pharmacy . No. View contact profiles from AIS Healthcare Popular Searches Ais Healthcare Ais Healthcare LLC The Counterclaim alleges that each time AIS improperly billed using the S9328 code it made a representation that it had performed those services when it had not. Id. Public Records Policy. Supply v. Boyles, Moak & Brickell Ins.,822 So.2d 323, 330 (Miss. Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. Appeal from the United States District Court . BCBS and AHS seek declaratory judgment, asking the Court to declare that BCBS has no contractual obligation to pay the alleged unpaid, mispresented claims. in Support of Mot. Advanced Infusion Solutions (AIS) Pharmaceutical Manufacturing Ridgeland, Mississippi 51 followers Follow View all 33 employees About us AIS HealthCare the leading provider of advanced sterile,. For the reasons stated, the Court DENIES AIS's Motion to Dismiss Counterclaim [56]. (Werner, Paul) (Entered: 03/11/2021), (#9) MOTION for Default Judgment as to Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions by Blue Cross Blue Shield of Michigan. at 14. Lead Counsel? A more recent docket listing "`Unjust enrichment' is a `modern designation for the doctrine of quasicontracts.'" 1 star. Blue Cross Blue Shield of Michigan v. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, US District Court for the Eastern District of Michigan, Minute Entry for proceedings before District Judge Denise Page Hood: Motion Hearing held on 6/23/2021 re #18 MOTION to Dismiss Plaintiff's Amended Complaint filed by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions Disposition: Motion taken under advisement (Court Reporter: Sheri Ward) (LSau). Generally, the rule "requires, at a minimum, that a plaintiff set forth the who, what, when, where, and how of the alleged fraud." Balloon Sleeve Big silhouette Over Shirt/ As of 01/01/2022 my insurance company was billed for and paid a part of a per diem of $120.00 . Good faith means "the faithfulness of an agreed purpose between two parties, a purpose which is consistent with justified expectations of the other party." RIDGELAND, MS 39157-6077. Release of Transcript Restriction set for 10/4/2021. Cases involving insurance agreements (subrogations, indemnifications, etc. Fax: 601-988-1701. Get billing and insurance guidance At AIS Healthcare, we want to make the billing and reimbursement process as easy as possible for you. [47] 54. 25. Repair Your Reputation The Right Way Corporate Advocacy Program It is located at 18451 Dallas Pkwy, Ste 125, Dallas, Texas 75287. Spokeo, 578 U.S. at 340-41). 1992) (citation omitted). [9659120-2] Initial AA Check Due satisfied. Use the links below to access additional information about this case on the US Court's PACER system. 2:21-CV-12966 | 2021-12-20. [Previously dismissed case: No] [Possible companion case(s): None] (Moody, Nolan) (Entered: 01/11/2021), U.S. Courts Of Appeals | Contract | R. Civ. R. Civ. 2010). 2008). [59] at 16. Industry: Health maintenance organization , Drug stores and proprietary stores Printer Friendly View Address: 623 Highland Colony Pkwy Ste 100 Ridgeland, MS, 39157-6077 United States See other locations Phone: Website: www.aiscaregroup.com Employees (this site): Actual ESG industry average: What is D&B's ESG Ranking? Want justice!? See AIS's Memo. Pasar al contenido principal LinkedIn. 03/16/2022. The Counterclaim also describes specific representations, see, e.g., id. Descubrir Personas Learning Empleos Unirse ahora . 2018) (quoting Bus. 21-30534 | 2021-08-27, U.S. District Courts | Contract | Advanced Infusion Solutions. Submit your story on our web site for free, for millions to see. for Women Alumnae Ass'n,998 So.2d 993, 998 (Miss. Infusion Solutions, LLC, was founded in 2020 by Annette Bennett and Lucien Roberts. [21-30534] REVIEWED AND/OR EDITED - The original text prior to review appeared as follows: UNOPPOSED MOTION filed by Appellant Mr. Randy Denning to supplement the record on appeal with Reasons in Support of Order granting Motion to Dismiss [9692325-2]. AIS, BCBSMS, BCBSA, and Advanced Health Systems, Inc. ("AHS") have settled all disputes arising out of, relating to, or concerning the claims and issues asserted by the parties to the legal proceedings in the lawsuit known as Bond Pharmacy d/b/a Advanced Infusion Solutions v. Id. Flaherty & Crumrine Preferred Income Fund Inc. v. TXU Corp.,565 F.3d 200, 206-07 (5th Cir. of Miss., LLC,250 So.3d 402, 415 (Miss. Cenac v. Murray,609 So.2d 1257, 1272 (Miss. Jul. Filed: August 27, 2021. (Winsten, I.) Id. texts to send an aries man Search. Provider Organization. Accepting these allegations as true, BCBS and AHS have plausibly stated both elements for breach of contract. According to BCBS and AHS, this was a special pharmacy function and did not warrant payment under the per diem S9328 code. No. 13. Id. [21-30534] (Paul Anthony Werner III) [Entered: 09/13/2021 03:26 PM], APPEARANCE FORM for the court's review. Document is insufficient for the following reasons: Motion does not contain a Certificate of Compliance. One of the HCPCS procedure codes in the Agreement is "HCPCS Code S9328". Provider Profile Details: Pharmacy Name. Ashcroft v. Iqbal,556 U.S. 662, 678 (2009) (citing Bell Atl. United States District Court, S.D. See Se Med. on CaseMine. Founders Chuck Bell Operating Status Active Company Type For Profit Phone Number 601.988.1700 AIS Healthcare is the provider of targeted drug delivery and infusion care. Id. Further, "[t]he existence of another adequate remedy does not preclude a declaratory judgment that is otherwise appropriate." Langham v. Behnen,39 So.3d 970, 976 (Miss. Id. County of 1st Plaintiff: Wayne - County Where Action Arose: Wayne - County of 1st Defendant: Out of State. How Much Do Advanced Infusion Solutions Jobs Pay per Year? Action: Case OK to Process. BCBS is an insurance company in Mississippi. A valid claim for relief contains "sufficient factual matter, accepted as true," giving the claim "facial plausibility" and allowing "the court to draw the reasonable inference that the defendant is liable for the misconduct alleged." 2:21-CV-00774 | 2021-04-16, U.S. District Courts | Contract | 2002). Escamilla v. Blue Cross Blue Shield of Michigan, d/b/a BCBSM, Wilber v. Compcare Health Services Insurance Corp et al, Mills v. Blue Cross Blue Shield Association et al, Nichols v. Blue Cross Blue Shield of Michigan, Michigan Catastrophic Claims Association v. Steadfast Insurance Company, Bradley v. Blue Cross Blue Shield of Michigan, Display Pack, Inc. v. LEL International, Inc. et al, Romano v. Blue Cross Blue Shield of Michigan. Electronic ROA deadline satisfied. If no request is filed, the transcript may be made remotely electronically available to the public without redaction after 90 days. [21-30534] (Roberta Louise Burns ) [Entered: 09/14/2021 10:55 AM], APPEARANCE FORM for the court's review. No. Plaintiff requests summons issued. . Id. (Court Reporter/Transcriber: Sheri Ward, www.transcriptorders.com) (Number of Pages: 21) The parties have 21 days to file with the court and Court Reporter/Transcriber a Redaction Request of this transcript. Id. (Entered: 05/12/2021), Docket(#23) NOTICE OF HEARING BY VIDEO CONFERENCE on #18 MOTION to Dismiss Plaintiff's Amended Complaint. (Entered: 03/04/2021), Docket(#7) ORDER for Extension of Time to Respond to Complaint #1 , ( Response due by 3/4/2021) Signed by District Judge Denise Page Hood. v. advanced infusion solutions lawsuit. Locations in Waukesha, West Bend, Sheboygan and Green Bay. If you do not agree with these terms, then do not use our website and/or services. (Cloutier, Kevin) (Entered: 04/29/2021), (#21) RESPONSE to #18 MOTION to Dismiss Plaintiff's Amended Complaint filed by Blue Cross Blue Shield of Michigan. (Attachments: #1 Index of Exhibits, #2 Exhibit 1 - Home Infusion Therapy Facility Participation Agreement, #3 Exhibit 2 - October 6, 2020 Letter from M. Martinez to J. Finley, #4 Exhibit 3 - October 16, 2020 Letter from P. Werner to M. Martinez) (Winsten, I.) Id. Blog We have designed private, spacious, comfortable, and relaxing suites which include: Heated massage chairs. Signed by District Judge Denise Page Hood. Doe v. MySpace, Inc.,528 F.3d 413, 418 (5th Cir. 4:22-CV-12577 | 2022-10-26, U.S. District Courts | Contract | The current location address for Advanced Infusion Solutions is 18451 Dallas Pkwy Ste 125, , Dallas, Texas and the contact number is 877-443-4006 and fax number is --. No. Defendant / Appellee: Bond Pharmacy, Incorporated, doing business as Advanced Infusion Care, doing business as Advanced Infusion Solutions, doing business as AIS Healthcare. 54. [47] 38. Namely, AIS contends they fail to establish the representation, materiality, and intent elements of the claim and to allege the "who, what, when, where, and how." The plausibility standard does not ask for a probability of unlawful conduct but does require more than a "sheer possibility." Plaintiff requests summons issued. Owned by: Advanced Infusion Solutions Acquisition, LLC Serial Number: 87399535. (dba The Wellness Pharmacy), Winchester, VA- 503A Facility, Kalman Health & Wellness, Inc. (dba Essential Wellness Pharma), Peoria, IL- 503A Facility, Kelley-Ross Compounding Pharmacy, Seattle, WA- 503A Facility, Key Compounding Pharmacy (see Puget Sound Drug Corporation), Federal Way, WA- 503A Facility, Keystone Pharmacy, Grand Rapids, MI- 503A Facility, Keystone Rx LLC, Bensalem, PA- 503A Facility, Kings Park Slope, Inc., Brooklyn, NY- 503A Facility - De-registered as an Outsourcing Facility, Kohana Pharmacy and Center for Regenerative Medicine Inc., San Luis Obispo, CA- 503A Facility, Kohll's Compounding, Omaha, NE- 503A Facility, Kona Community Hospital Pharmacy, (see Hawaii Health Systems Corporation), Kealakekua, HI- 503A Facility, KRS Global Biotechnology, Inc. Boca Raton, FL- 503B Facility, Ladd Family Pharmacy LLC, Boise, ID- 503A Facility, Lato Drug Company, Inc. (dba Post Haste Pharmacy), Hollywood, FL- 503A Facility, La Vita Compounding Pharmacy, LLC, San Diego, CA- 503A Facility, Lee and Company (dba Lee Pharmacy, Inc.), Fort Smith, AR- 503A Facility - Out of business, Lee Pharmacy, Inc.(see Lee and Company), Fort Smith, AR- 503A Facility, LeeSar, Inc., Fort Myers, FL- 503B Facility, Lee Silsby Compounding Pharmacy, (see Gipsco Investment Corp.), Cleveland Heights, OH- 503A Facility, Leiter's Cambrian Park Drugs, Inc., (dbaLeiter's Compounding Pharmacy), 1700 Park Avenue, San Jose, CA- 503A Facility - Out of business, Leiter's Compounding, 17 Great Oaks Blvd., San Jose, CA- 503A Facility, Leiter's Compounding Pharmacy,(see Leiter's Cambrian Park Drugs, Inc.), San Jose, CA- 503A Facility, Leiter's Health, (see Denver Solutions, LLC), Englewood, CO- 503A Facility, Liberty Drug and Surgical, Chatham, NJ- 503A Facility, Life Science Pharmacy, Inc., Harriman, NY- 503A Facility, Lifetime Value Pharmacy III Inc., Santa Ana, CA- 503A Facility, Lincare, Inc. (dba United Medical Home Infusion), Little Rock, AR- 503A Facility, Lloyd Central Compounding Pharmacy, (see Portland Compounding Pharmacy, LLC), Portland, OR- 503A Facility, Loop Pharmacy & Home Medical, Saint Albans, WV- 503A Facility, Louisville Pharmacy (see Spoonamore Drug Co., Inc.), Louisville, KY- 503A Facility, Lowlite Investments, Inc. (dba Olympia Pharmacy), Orlando, FL- 503A Facility, Lowlyn Pharmacies, Inc. (dba Red Cross Drug), Blanchard, OK- 503A Facility, Lynnfield Drug, Inc. (dba Freedom Fertility Pharmacy), Byfield, MA- 503A Facility, Lynn Oaks Compounding Pharmacy, Thousand Oaks, CA - 503A Facility, M Drug, LLC, (dba Northern Light Pharmacy), Bangor, ME- 503A Facility, Maag Prescription Center LLC, Pocatello, ID- 503A Facility, Madison Drugs (see Service First Pharmacies, Inc.), Huntsville, AL- 503A Facility, Magellan Rx Pharmacy LLC, Astoria, NY- 503A Facility, Maimonides Medical Center-Pharmacy, Brooklyn, NY- 503A Facility, Main Street Family Pharmacy, Newbern, TN- 503A Facility - Out of business, Maitland Labs of Central Florida, Orlando, FL- 503A Facility - Out of business, Malley's Compounding Pharmacy, (see Columbia River Pharmacy, LLC), Richland, WA- 503A Facility, Malanda, Inc., (dba Mandell's Clinical Pharmacy), Somerset, NJ- 503A Facility, Maplerose Enterprises, LLC (dba Pencol Pharmacy), Denver, CO- 503A Facility, Mark Drugs Pharmacy, (see Snyder Mark Drugs Roselle, Inc.), Roselle, IL- 503A Facility, Martin Avenue Pharmacy, Inc., Naperville, IL- 503A Facility, Maryland Specialty and Compounding, LLC dba Professional Arts Pharmacy, Baltimore, MD- 503A Facility - Ceased sterile compounding, MasterPharm LLC. 16. UniCourt uses cookies to improve your online experience, for more information please see our Privacy Policy. All rights reserved New Patient Forms; Cooperative . Advanced Infusion Solutions (AIS) Pharmaceutical Manufacturing Ridgeland, Mississippi 41 followers See jobs Follow View all 32 employees Report this company About us AIS HealthCare the leading provider of advanced sterile, patient-specific intrathecal pump medications and in-home intravenous infusion including immune globulin therapies.